A comparison of pediatric and adult neuromyelitis optica spectrum disorders: A review of clinical manifestation, diagnosis, and treatment
Open Access
- 1 May 2018
- journal article
- review article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 388, 222-231
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitionsMultiple Sclerosis Journal, 2013
- Aquaporin 4 and neuromyelitis opticaThe Lancet Neurology, 2012
- Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal ArraysJournal of Biological Chemistry, 2012
- Aquaporins in Clinical MedicineAnnual Review of Medicine, 2012
- Neutrophil protease inhibition reduces neuromyelitis optica–immunoglobulin G–induced damage in mouse brainAnnals of Neurology, 2011
- Beneficial Plasma Exchange Response in Central Nervous System Inflammatory DemyelinationArchives of Neurology, 2011
- Current and future treatment approaches for neuromyelitis opticaTherapeutic Advances in Neurological Disorders, 2011
- Anti-Aquaporin-4 Antibody-Positive Neuromyelitis Optica Presenting with Syndrome of Inappropriate Antidiuretic Hormone Secretion as an Initial ManifestationCase Reports in Neurology, 2011
- Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in miceBrain, 2010
- Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis opticaAnnals of Neurology, 2009